ClinicalTrials.govpublic full text
Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI
stemi, stemi (st elevation mi), stemi - st elevation myocardial infarction (mi), stent implantation, atibuclimab, ic14, monoclonal antibody against cd14, anti-cd14, antiinflammatory, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1008271
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.